Literature DB >> 10748070

Glycosylation efficiency of Asn-Xaa-Thr sequons depends both on the distance from the C terminus and on the presence of a downstream transmembrane segment.

I Nilsson1, G von Heijne.   

Abstract

Statistical studies of N-glycosylated proteins have indicated that the frequency of nonglycosylated Asn-Xaa-(Thr/Ser) sequons increases toward the C terminus (Gavel, Y., and von Heijne, G. (1990) Protein Eng. 3, 433-442). Using in vitro transcription/translation of a truncated model protein in the presence of dog pancreas microsomes, we find that glycosylation efficiency of Asn-Xaa-Thr sequons indeed is reduced when the sequon is within approximately 60 residues of the C terminus. Surprisingly, the presence of a hydrophobic stop transfer sequence between the Asn-Xaa-Thr sequon and the C terminus results in a very different dependence of glycosylation efficiency on the distance to the C terminus, where the presence of the stop transfer segment inside the ribosome appears to cause a drastic drop in the level of glycosylation. We speculate that this may reflect a change in the structure of the ribosome/translocon complex induced by the stop transfer segment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10748070     DOI: 10.1074/jbc.M002317200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  Stop-transfer efficiency of marginally hydrophobic segments depends on the length of the carboxy-terminal tail.

Authors:  Tara Hessa; Magnus Monné; Gunnar von Heijne
Journal:  EMBO Rep       Date:  2003-02       Impact factor: 8.807

2.  Distance of sequons to the C-terminus influences the cellular N-glycosylation of the prion protein.

Authors:  Adrian R Walmsley; Nigel M Hooper
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

3.  The protease-associated domain and C-terminal extension are required for zymogen processing, sorting within the secretory pathway, and activity of tomato subtilase 3 (SlSBT3).

Authors:  Anna Cedzich; Franziska Huttenlocher; Benjamin M Kuhn; Jens Pfannstiel; Leszek Gabler; Annick Stintzi; Andreas Schaller
Journal:  J Biol Chem       Date:  2009-03-30       Impact factor: 5.157

4.  ADAMDEC1 is a metzincin metalloprotease with dampened proteolytic activity.

Authors:  Jacob Lund; Ole H Olsen; Esben S Sørensen; Henning R Stennicke; Helle H Petersen; Michael T Overgaard
Journal:  J Biol Chem       Date:  2013-06-10       Impact factor: 5.157

5.  Post-translational N-glycosylation of type I transmembrane KCNE1 peptides: implications for membrane protein biogenesis and disease.

Authors:  Tuba Bas; Grace Y Gao; Anatoli Lvov; Kshama D Chandrasekhar; Reid Gilmore; William R Kobertz
Journal:  J Biol Chem       Date:  2011-06-15       Impact factor: 5.157

6.  Efficient glycosylphosphatidylinositol (GPI) modification of membrane proteins requires a C-terminal anchoring signal of marginal hydrophobicity.

Authors:  Carmen Galian; Patrik Björkholm; Neil Bulleid; Gunnar von Heijne
Journal:  J Biol Chem       Date:  2012-03-19       Impact factor: 5.157

7.  Molecular basis of the first reported clinical case of congenital combined deficiency of coagulation factors.

Authors:  Da-Yun Jin; Brian O Ingram; Darrel W Stafford; Jian-Ke Tie
Journal:  Blood       Date:  2017-07-05       Impact factor: 22.113

8.  Surface Glycoproteomic Analysis Reveals That Both Unique and Differential Expression of Surface Glycoproteins Determine the Cell Type.

Authors:  Suttipong Suttapitugsakul; Lindsey D Ulmer; Chendi Jiang; Fangxu Sun; Ronghu Wu
Journal:  Anal Chem       Date:  2019-05-03       Impact factor: 6.986

9.  Characterization of glycosylation sites of the epidermal growth factor receptor.

Authors:  Yuejun Zhen; Richard M Caprioli; James V Staros
Journal:  Biochemistry       Date:  2003-05-13       Impact factor: 3.162

10.  Signal peptide requirements for lymphocytic choriomeningitis virus glycoprotein C maturation and virus infectivity.

Authors:  Sabrina Schrempf; Marc Froeschke; Tsanan Giroglou; Dorothee von Laer; Bernhard Dobberstein
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.